다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
International journal of molecular medicine, v.34 no.1, 2014년, pp.183 - 190
LEE, JONG SEOK (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA) , KO, EUN-JU (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA) , HWANG, HYE SUK (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA) , LEE, YU-NA (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA) , KWON, YOUNG-MAN (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA) , KIM, MIN-CHUL (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA) , KANG, SANG-MOO (Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA)
AI-Helper
Panax ginseng has been known to have a number of immuno-modulatory effects. In this study, we investigated whether Panax Korean red ginseng extract (KRGE) has in vitro and in vivo antiviral effects on respiratory syncytial virus (RSV) infection. KRGE improved the survival of human lung epithelial ce...
1 Murphy BR Prince GA Collins PL Van Wyke Coelingh K Olmsted RA Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses Virus Res 11 1 15 1988 2845680
2 Kim HW Canchola JG Brandt CD Pyles G Chanock RM Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine Am J Epidemiol 89 422 434 1969 4305198
3 Collins PL Graham BS Viral and host factors in human respiratory syncytial virus pathogenesis J Virol 82 2040 2055 2008 17928346
4 Chin J Magoffin RL Shearer LA Schieble JH Lennette EH Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population Am J Epidemiol 89 449 463 1969 4305200
5 Fulginiti VA Eller JJ Sieber OF Joyner JW Minamitani M Meiklejohn G Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine Am J Epidemiol 89 435 448 1969 4305199
6 Garofalo RP Kolli D Casola A Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities Antioxid Redox Signal 18 186 217 2013 22799599
7 Becker S Soukup J Yankaskas JR Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages Am J Respir Cell Mol Biol 6 369 374 1992 1550681
8 Hong CE Lyu SY Anti-inflammatory and anti-oxidative effects of Korean red ginseng extract in human keratinocytes Immune Netw 11 42 49 2011 21494373
9 Culley FJ Pennycook AM Tregoning JS Hussell T Openshaw PJ Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology J Virol 80 4521 4527 2006 16611912
10 Jiang Z Kunimoto M Patel JA Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus J Virol 72 2496 2499 1998 9499112
11 Hammad H Lambrecht BN Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma Nat Rev Immunol 8 193 204 2008 18301423
12 Kwok HH Ng WY Yang MS Mak NK Wong RN Yue PY The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status Free Radic Biol Med 48 437 445 2010 19932166
13 Chan LY Kwok HH Chan RW Peiris MJ Mak NK Dual functions of ginsenosides in protecting human endothelial cells against influenza H9N2-induced inflammation and apoptosis J Ethnopharmacol 137 1542 1546 2011 21872652
14 Moore ML Chi MH Luongo C Lukacs NW Polosukhin VV A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction J Virol 83 4185 4194 2009 19211758
15 Quan FS Kim Y Lee S Yi H Kang SM Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice J Infect Dis 204 987 995 2011 21881112
16 Panuska JR Merolla R Rebert NA Hoffmann SP Tsivitse P Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity J Clin Invest 96 2445 2453 1995 7593633
17 Arnold R König B Galatti H Werchau H König W Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection Immunology 85 364 372 1995 7558123
18 Zhang Y Luxon BA Casola A Garofalo RP Jamaluddin M Brasier AR Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays J Virol 75 9044 9058 2001 11533168
19 Lee DC Lau AS Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review Molecules 16 2802 2816 2011 21455094
20 Legg JP Hussain IR Warner JA Johnston SL Warner JO Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis Am J Respir Crit Care Med 168 633 639 2003 12773328
21 Matsuse H Hirose H Tsuchida T Fukahori S Fukushima C Effects of respiratory syncytial virus infection on dendritic cells and cysteinyl leukotrienes in lung tissues of a murine model of asthma Allergol Int 56 165 169 2007 17460444
22 Song JM Hossain J Yoo DG Lipatov AS Davis CT Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles Virology 405 165 175 2010 20580392
23 Song JM Van Rooijen N Bozja J Compans RW Kang SM Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus Proc Natl Acad Sci USA 108 757 761 2011 21187388
24 Attele AS Wu JA Yuan CS Ginseng pharmacology: multiple constituents and multiple actions Biochem Pharmacol 58 1685 1693 1999 10571242
25 Jie YH Cammisuli S Baggiolini M Immunomodulatory effects of Panax Ginseng C.A. Meyer in the mouse Agents Actions 15 386 391 1984 6084415
26 Pulendran B Modulating vaccine responses with dendritic cells and Toll-like receptors Immunol Rev 199 227 250 2004 15233738
27 Panuska JR Midulla F Cirino NM Villani A Gilbert IA Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2 Am J Physiol 259 L396 L402 1990 2260674
28 Zeng R Li C Li N Wei L Cui Y The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma Cytokine 53 1 7 2011 21035355
29 Cormier SA You D Honnegowda S The use of a neonatal mouse model to study respiratory syncytial virus infections Expert Rev Anti Infect Ther 8 1371 1380 2010 21133663
30 Mata M Morcillo E Gimeno C Cortijo J N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV) Biochem Pharmacol 82 548 555 2011 21635874
31 Watanabe W Shimizu T Sawamura R Hino A Konno K Effects of tetrabromobisphenol A, a brominated flame retardant, on the immune response to respiratory syncytial virus infection in mice Int Immunopharmacol 10 393 397 2010 20074668
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.